Globus is a tool that UWyo uses for transfer of large data files or collections with collaborators that don’t have easy access otherwise. It allows you to assign read or write permissions. You can ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market ...

Globus Medical Inc. (NYSE ... marking a 45% year-over-year growth. InvestingPro data reveals the company's strong financial position, with a healthy current ratio of 2.51 and sufficient cash ...

Across the recent three months, 11 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

Net income rose by 77% to $26.5 million, highlighting significant growth. Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full ...

Globus Medical announced robust revenue growth for Q2 2024, driven by the NuVasive acquisition, but faced significant declines in GAAP net income.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Globus Medical's market standing. Stay informed and make data-driven ...

Charles Schwab Investment Management Inc. lowered its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure ...

Explore Globus Medical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GMED. Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024 ...